TGFB1 and cholangiocarcinoma: Furthermore, the activation of pathways involving TGF-β, B7-H1/PD-1, and Fas/FasL has been observed in the cholangiocarcinoma microenvironment, which hampers the proliferation and activity of CD8+ T lymphocytes (71).